NCT07412379 Predictive Factors for Functional and Quality of Life Decline in Patients >65 Years With a Gastrointestinal Tract Cancer Diagnosis Taken to Curative Resectable Surgery
| NCT ID | NCT07412379 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Universitario Mayor Méderi |
| Condition | Cancer Abdomen |
| Study Type | OBSERVATIONAL |
| Enrollment | 327 participants |
| Start Date | 2026-01-13 |
| Primary Completion | 2029-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 327 participants in total. It began in 2026-01-13 with a primary completion date of 2029-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Introduction: Human life expectancy has increased significantly, leading to a transformation in the global demographic structure. Cancer is considerably more common among older adults compared to younger populations, as age is one of the main risk factors for its development. In fact, most solid tumors are considered age-related diseases. For this reason, the incidence of cancer among older individuals is expected to continue rising. Oncological care for this population group is particularly complex and represents a significant challenge, as comorbidities and the social aspects of aging create clinical scenarios that differ greatly from those seen in younger patients. Objective: To identify the predictive factors of functional decline and quality of life at 12 months of follow-up, as well as oncological outcomes at 5 years of follow-up, in patients aged 65 years and older with gastrointestinal cancer who undergo curative-intent resective surgery at Hospital Universitario Mayor - Méderi, Bogotá, Colombia. Methodology: Longitudinal and analytical observational study of prospective prognostic cohort type. Expected Results: Predictive model of functional decline and quality of life, as well as oncological outcomes, in patients with gastrointestinal cancer undergoing curative-intent surgical procedures.
Eligibility Criteria
Inclusion Criteria: * Gastrointestinal cancer tract diagnosis (oesophagus, stomach, duodenum, pancreas, liver, biliary tract, small bowel, appendix, colon and rectum) * Have resectable disease by surgery * Taken to surgery by curative intent * Willingness to participate and enrollment by informed consent * Attended in the Mederi Hospital Networn Exclusion Criteria: * Mortality * Loss to follow-up * Not taken to surgery * Emergency surgery * Taken to surgery as an oncological relapse or due to complications previous to an index procedure * Endoscopical treatment * Second primary tumor without a minimum 5 year disease free period from the primary one * Basal functionality 0/6 by Katz score.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07412379 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Cancer Abdomen. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07412379 currently recruiting?
Yes, NCT07412379 is actively recruiting participants. Contact the research team at ramirezgiraldocamilo@gmail.com for enrollment information.
Where is the NCT07412379 trial being conducted?
This trial is being conducted at Bogotá, Colombia.
Who is sponsoring the NCT07412379 clinical trial?
NCT07412379 is sponsored by Hospital Universitario Mayor Méderi. The trial plans to enroll 327 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.